Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review

BACKGROUND: Treatment beyond progression with immunotherapy may be appropriate in selected patients based on the potential for late responses. The aim of this systematic review was to explore the impact of treatment beyond progression in patients receiving an anti-PD-1/PD-L1 based regimen for an adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Spagnolo, Francesco, Boutros, Andrea, Cecchi, Federica, Croce, Elena, Tanda, Enrica Teresa, Queirolo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052683/
https://www.ncbi.nlm.nih.gov/pubmed/33865350
http://dx.doi.org/10.1186/s12885-021-08165-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052683/
https://www.ncbi.nlm.nih.gov/pubmed/33865350
http://dx.doi.org/10.1186/s12885-021-08165-0

Ejemplares similares